EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India

Abhilash Vasanth iD, Shilpa M Patel iD, Ruchi Arora iD, Chetana D Parekh iD, Pariseema Dave iD, Bijal M Patel iD, Priyanka Vemanamandhi iD

Journal of Gynecologic Oncology · 2024

DOI: 10.3802/jgo.2024.35.e19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Abhilash Vasanth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecological Oncology, The Gujarat Cancer and Research Institute, M P Shah Cancer Hospital, Ahmedabad, India. Hauptthemen laut MEDLINE: Dysgerminoma, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To study clinical characters and outcomes in patients of malignant ovarian germ cell tumor (MOGCT) undergoing surgery following neoadjuvant chemotherapy (NACT). METHODS: Retrospective study of patients undergoing surgery following NACT for MOGCT at our institute. Platinum based chemotherapy was given in all patients in NACT. RESULTS: Between March 2013 and February 2023, 30 patients had surgery after NACT. Patient's median age was 22 years (range, 12 to 35 years) and median follow up 42months (range, 6 to 132 months). Majority had endodermal sinus tumor (n=12), dysgerminoma (n=9) and mixed GCT (n=7). All had either International Federation of Gynecology and Obstetrics (FIGO) stage 3 (n=19) or FIGO stage 4 disease (n=11). Complete response to NACT seen in 5 patients and 23 patients had partial response. Fertility sparing surgery in 18 patients and complete surgery in 12 patients. Suboptimal surgery was seen in 4 patients. Currently, 20 of 30 patients are alive and disease free, 3 lost for follow up and 7 patients had progression after adjuvant therapy. Five patients had mortality-4 with progression and 1 with bleomycin toxicity. Fifteen of 17 eligible patients have resumed menstruation and one had successful pregnancy. Prognostic factors noted in study are stage, optimal surgery and viable tumor in histopathology. Dysgerminoma had better outcome than other histology. CONCLUSION: NACT may be a reasonable option in patients with extensive unresectable disease or in whom fertility sparing is not possible or in the poor general condition. Fertility sparing surgery can be attempted post neoadjuvant chemotherapy without adversely affecting prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysgerminomaOvarian NeoplasmsNeoplasms, Germ Cell and EmbryonalPregnancyFemaleHumansYoung AdultAdultNeoadjuvant TherapyRetrospective StudiesChemotherapy, AdjuvantNeoplasm Staging

Stichwörter der Autor:innen

Fertility PreservationNeoadjuvant TherapyNeoplasm Germ Cell and EmbryonalOvarian Neoplasm

Autor:innen und Institutionen

  • Department of Gynaecological Oncology, The Gujarat Cancer and Research Institute, M P Shah Cancer Hospital, Ahmedabad, India.
  • Department of Gynaecological Oncology, The Gujarat Cancer and Research Institute, M P Shah Cancer Hospital, Ahmedabad, India. drshilpamukesh@gmail.com.

ORCID-Profile: Abhilash Vasanth, Shilpa M Patel, Ruchi Arora, Chetana D Parekh, Pariseema Dave, Bijal M Patel, Priyanka Vemanamandhi

Zitieren

APA

Vasanth, A., Patel, S. M., Arora, R., Parekh, C. D., Dave, P., Patel, B. M., & Vemanamandhi, P. (2024). Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2024.35.e19

Vancouver

Vasanth A, Patel SM, Arora R, Parekh CD, Dave P, Patel BM, et al. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India. Journal of Gynecologic Oncology. 2024. doi:10.3802/jgo.2024.35.e19

BibTeX
@article{Vasanth2024,
  author = {Vasanth, Abhilash and Patel, Shilpa M and Arora, Ruchi and Parekh, Chetana D and Dave, Pariseema and Patel, Bijal M and Vemanamandhi, Priyanka},
  title = {Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India},
  journal = {Journal of Gynecologic Oncology},
  year = {2024},
  doi = {10.3802/jgo.2024.35.e19}
}
Kostenlos starten →